Results 241 to 250 of about 52,862 (295)

Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis. [PDF]

Pharmacoecon Open
Flanigan J, Kane S, Mirzayeh Fashami F, Zhou A, Almuallem L, Tindal M, Schauf M, Li E, Lyman GH.   +8 more
europepmc   +1 more source

Longitudinal osteoporosis therapy: treat-to-target and sequential strategies-a narrative review. [PDF]

Ther Adv Musculoskelet Dis
Tskhakaia I, Danila MI.
europepmc   +1 more source

Bisphosphonate-induced Esophagitis Dissecans Superficialis: A Rare Case Report. [PDF]

Ann Afr Med
Bade Y, Ahmed J, Bharti V.
europepmc   +1 more source

Practical approach to the diagnosis, management, and treatment of pediatric patients with bone fragility: an expert opinion. [PDF]

J Endocrinol Invest
Baroncelli GI, Tessaris D, Aversa T, Bertelli E, Comberiati P, Corica D, Di Iorgi N, Faienza MF, Fintini D, Franceschi R, Grandone A, Karapurackal MA, Longhi S, Pitea M, Secco A, Trifirò G, Ubertini G, Urbano F, Vierucci F, Wasniewska M, Mora S, de Sanctis L.   +21 more
europepmc   +1 more source

Bisphosphonates

Annals of the New York Academy of Sciences, 2006
Abstract:  Bisphosphonates belong to a class of compounds similar to pyrophosphate. In these compounds the oxygen atom of the pyrophosphate is replaced by a carbon atom resulting in a P‐C‐P bond. They exert a potent inhibitory effect on osteoclasts and are therefore potent antiresorptive agents. They reduce bone turnover, increase bone mineral density,
Robert Graham Goodwin Russell, R Graham G Russell   +1 more
exaly   +4 more sources

Bisphosphonates [PDF]

European Journal of Cancer, 1998
info:eu-repo/semantics ...
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Bisphosphonates and Bisphosphonate Induced Osteonecrosis

Oral and Maxillofacial Surgery Clinics of North America, 2007
Bisphosphonate-induced osteonecrosis of the jaws is the correct term for this real drug complication that most dental practitioners face. All nitrogen-containing bisphosphonates pose a risk, which is related to the route of administration, the potency of the bisphosphonate, and the duration of use.
Yoh, Sawatari, Robert E, Marx
openaire   +2 more sources

Bisphosphonates and Osteoporosis

New England Journal of Medicine, 2002
Osteoporosis affects millions of postmenopausal women in the United States alone. For white women who reach 50 years of age, the lifetime risk of vertebral fracture is about one in three, and that for hip fracture is one in six. One tenth to one fifth of the women who have a hip fracture die within a year after it occurs, and one quarter must move ...
openaire   +4 more sources

Pharmacology of bisphosphonates

Bone, 2011
Four decades of preclinical and clinical research of the pharmacology of bisphosphonates have generated data and concepts that have considerably improved their clinical use. However, despite this progress several pharmacological aspects relevant to bisphosphonate action on bone are still incompletely understood.
Serge Cremers, Socrates E Papapoulos
exaly   +4 more sources

Bisphosphonates in oncology

Bone, 2011
Bone metastases result in considerable morbidity, often affecting quality of life and independence over years, and may place complex demands on health care resources. The bisphosphonates have been shown to reduce skeletal morbidity in multiple myeloma and solid tumours affecting bone by 30-50%.
Robert E, Coleman, Eugene V, McCloskey
openaire   +2 more sources